Centre Number
Candidate Number
Write your name here
Surname
Other names
Total Marks
Paper Reference
     Turn over
*N35899A0124*
Edexcel GCE
Biology
Advanced Subsidiary
Unit 1:  Lifestyle, Transport, Genes and Health
Tuesday 12 January 2010 – Morning
Time: 1 hour 30 minutes
You do not need any other materials.
6BI01/01
Instructions
• Use black ink or ball-point pen.
• Fill in the boxes at the top of this page with your name, 
 
centre number and candidate number.
• Answer all questions.
• Answer the questions in the spaces provided 
 
– there may be more space than you need.
Information
• The total mark for this paper is 80.
• The marks for each question are shown in brackets
 
– use this as a guide as to how much time to spend on each question.
• Questions labelled with an asterisk (*) are ones where the quality of your 
 
written communication will be assessed 
 
 – you should take particular care with your spelling, punctuation and grammar, as 
well as the clarity of expression, on these questions.
• Candidates may use a calculator.
Advice
• Read each question carefully before you start to answer it.
• Keep an eye on the time.
• Try to answer every question.
• Check your answers if you have time at the end.
N35899A
©2010 Edexcel Limited.
1/1/1/1/1/
PMT


--- Page Break ---

2
*N35899A0224*
Answer ALL questions.
Some questions must be answered with a cross in a box .  If you change your mind about an 
answer, put a line through the box 
 and then mark your new answer with a cross .
1 DNA is a very important molecule in living organisms as it carries the genetic code 
that controls all characteristics.  When a cell divides, the DNA molecule replicates so 
that each resulting daughter cell is genetically identical to the original parent cell.
 
The diagram below shows part of this process of DNA replication.


























Part of new
DNA molecule
J
K
L
N
P
M
O
Part of parent 
DNA molecule
PMT


--- Page Break ---

3
*N35899A0324*
Turn over  
 
For each of the statements below, put a cross in the box that corresponds to the 
correct statement about DNA structure or DNA replication.
 
(a) The structure labelled J is 
(1)
 
 
 
A ribose
 
 
 
B α glucose
 
 
 
C β glucose
 
 
 
D deoxyribose 
 
(b) The structure labelled K is a
(1)
 
 
 
A phosphate group
 
 
 
B phosphorus atom
 
 
 
C sulphate group
 
 
 
D potassium atom
 
(c) The bond labelled L is a
(1)
 
 
 
A peptide bond
 
 
 
B phosphodiester bond
 
 
 
C hydrogen bond
 
 
 
D glycosidic bond
 
(d) The structure labelled M is a
(1)
 
 
 
A polynucleotide
 
 
 
B mononucleotide
 
 
 
C polypeptide
 
 
 
D mononucleoside
PMT


--- Page Break ---

4
*N35899A0424*
 
(e) If the base labelled N on the parent DNA molecule is adenine, the base labelled O 
on the new DNA molecule is
(1)
 
  
A uracil
 
  
B guanine
 
  
C thymine
 
  
D cytosine
 
(f) The bond labelled P is a
(1)
 
  
A peptide bond
 
  
B phosphodiester bond
 
  
C hydrogen bond
 
  
D glycosidic bond
(Total for Question 1 = 6 marks)
PMT


--- Page Break ---

5
*N35899A0524*
Turn over  
2 Read through the following passage on protein synthesis, then write on the dotted 
lines the most appropriate word or words to complete the passage.
(6)
 
Protein synthesis involves two stages.  The first stage is ................................................................. and
 
takes place in the nucleus of the cell.  During this stage, a molecule called
 
................................................................. is made using the antisense DNA strand as a template.
 
The second stage, known as ................................................................. , takes place in the cytoplasm of
 
the cell on structures called  ................................................................. .  During this stage,
 
 .................................................................  molecules enable the amino acids attached to them to line
 
up in the correct order.  The amino acids are joined together by the formation of
 
 ................................................................. bonds.
(Total for Question 2 = 6 marks)
PMT


--- Page Break ---

6
*N35899A0624*
3 Amoeba is a single-celled aquatic organism.  Substances in the water can enter the 
cell by a variety of mechanisms.
 
An experiment was carried out to compare the uptake into Amoeba of substance A 
and substance B.
 
Some of these organisms were placed in a solution containing equal concentrations 
of both substances and kept at 25 °C.  The concentration of substances A and B, in the 
cytoplasm of these organisms, was measured every 30 minutes over a period of
5 hours.
 
The results of this experiment are shown in the graph below.
 
(a) Using the information in the graph, compare the uptake of substance A with the 
uptake of substance B during this period of 5 hours.
(3)
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
Concentration of substance in 
cytoplasm / µg cm–3
15
10
5
0
0
1
2
3
4
5
Substance A
Substance B
Time / hours
PMT


--- Page Break ---

7
*N35899A0724*
Turn over  
 *(b) Substance B enters the cells by diffusion.  Describe and explain how the results of 
this experiment support this statement.
(4)
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
 
(c) Substance A enters the cells by active transport.  Give two differences between 
active transport and diffusion.
(2)
1 ...........................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
2 ...........................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
(Total for Question 3 = 9 marks)
PMT


--- Page Break ---

8
*N35899A0824*
4 Many animals have hearts that pump blood through a network of blood vessels.
 
(a) The table below refers to blood flow in the four major blood vessels of the human 
heart.  If the statement is correct, place a tick (9) in the appropriate box and if the 
statement is incorrect, place a cross (8) in the appropriate box.
(4)
Name of blood vessel
Carries blood away 
from the heart
Carries oxygenated 
blood
Aorta
Vena cava
Pulmonary artery
Pulmonary vein
 
(b) Humans and fish are both animals that have a heart and a network of blood 
vessels.  However, there are some differences in their circulatory systems.
 
 
The diagrams below illustrate a human circulatory system and the circulatory 
system in a fish.
                    Human circulatory system                                            Fish circulatory system
The arrows show the direction of blood flow.
Body
Heart 
Lungs
Body
Heart 
Gills
PMT


--- Page Break ---

9
*N35899A0924*
Turn over  
 
 
(i) 
Using the information in the diagram, describe the circulation of blood in a 
fish.
(3)
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
 
 
(ii) Using the information in both diagrams, suggest the advantages that the 
human circulatory system has compared with that of a fish.
(2)
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
PMT


--- Page Break ---

10
*N35899A01024*
 
(c) The heart of an insect is a long tube.  It pumps blood into the body cavity so that 
blood surrounds the cells.  The blood then passes back into the heart from the 
body cavity.
 
 
The diagram below illustrates the circulatory system of an insect.
 
 
Suggest why the insect does not need blood vessels to transport its blood around 
the body.
(2)
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
(Total for Question 4 = 11 marks)
Flow of blood into 
the body cavity
Blood passes back 
into the heart
Heart
PMT


--- Page Break ---

11
*N35899A01124*
Turn over  
5 There are many venomous (poisonous) snakes in the world.  Many of the venoms 
from these snakes affect the blood clotting process.
 *(a) Describe the blood clotting process.
(4)
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
PMT


--- Page Break ---

12
*N35899A01224*
 
(b) Factor Xa is a clotting factor present in human blood.
 
 
An experiment was carried out to investigate the time taken for human blood 
to clot in the presence of different masses of Factor Xa.  The experiment was 
repeated using snake venom in place of Factor Xa.
 
 
The graph below shows the results of these experiments.  
 
 
(i) 
Using the information in the graph, describe the effect of the snake venom on 
the clotting time of human blood.
(3)
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
Clotting time of human 
blood / seconds
140
120
100
80
60
40
20
0
160
180
200
Mass added / µg
0
0.04
0.08
0.12
0.16
0.20
Factor Xa present
Snake venom present
PMT


--- Page Break ---

13
*N35899A01324*
Turn over  
 
 
(ii) Suggest why the clotting time of the human blood with snake venom added 
was compared with the clotting time in the presence of Factor Xa.
(1)
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
 
(c) The component of the snake venom that affects blood clotting is an enzyme.
 
 
(i) 
Describe the structure of an enzyme.
(3)
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
 
 
(ii) Suggest how the enzyme in the snake venom could be involved in the blood 
clotting process.
(2)
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
(Total for Question 5 = 13 marks)
PMT


--- Page Break ---

14
*N35899A01424*
6 A number of different drinks contain the drug caffeine.  These drinks may be 
consumed to increase mental alertness.  Caffeine also increases the heart rate and can 
interrupt sleep in some people.
 
A student found that certain drinks affected her sleep, so she carried out some 
research into the caffeine content of these drinks.  The graph below shows the 
caffeine content of the drinks that the student researched.
Caff eine content per serving / mg
130
120
110
100
90
80
70
60
50
40
30
20
10
0
Coffee
Black
Tea
Oolong
Tea
White
Tea
Green
Tea
Cocoa
Type of drink
140
PMT


--- Page Break ---

15
*N35899A01524*
Turn over  
 
(a) Using the information in the graph, describe the conclusions that the student 
could make about the caffeine content of these drinks.
(3)
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
PMT


--- Page Break ---

16
*N35899A01624*
 
(b) A friend of the student suggested that herbal tea might have a lower caffeine 
content than these drinks.  The student decided to use Daphnia to compare the 
caffeine content of herbal tea with the caffeine content of these other drinks.
 
 
(i) 
Describe an experiment that the student could perform, using Daphnia, to 
confirm that herbal tea has the lowest caffeine content.
(4)
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
PMT


--- Page Break ---

17
*N35899A01724*
Turn over  
 
 
(ii) The friend did not agree with using Daphnia in this experiment.  Give one 
ethical reason for the use of invertebrates and one ethical reason against the 
use of invertebrates in experiments of this type.
(2)
Reason for the use of invertebrates  ................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
Reason against the use of invertebrates  ....................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
(Total for Question 6 = 9 marks)
PMT


--- Page Break ---

18
*N35899A01824*
7 Cystic fibrosis is a life-threatening condition that can affect many different parts of 
the body.  It is a recessive genetic trait.  Genetic screening can be used to test for the 
presence of recessive alleles.  A person found to possess a recessive allele is called a 
carrier.
 
The diagram below illustrates a risk analysis following the screening for recessive 
alleles of a couple, who are planning a pregnancy.
 
(a) Suggest why cells from mouth swabs or blood samples are used rather than 
gametes.
(2)
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
Neither partner is a 
carrier
One partner is a 
carrier
Both partners are 
carriers
Low chance of cystic 
fibrosis in offspring
Low chance of cystic 
fibrosis in offspring
•  Prenatal testing of fetus 
offered
•  Preimplantation diagnosis 
offered
•  Possible use of donor 
gamete if woman not yet 
pregnant
High chance of cystic 
fibrosis in offspring
•  Genetic counselling 
of carrier partner
•  Testing of other 
members of the 
family offered
•  No further tests 
required
Screening of the cells from mouth swabs or blood samples 
from each partner
PMT


--- Page Break ---

19
*N35899A01924*
Turn over  
 
(b) Explain why it is necessary to test for several different recessive alleles in the 
screening for cystic fibrosis.
(2)
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
 
(c) In the risk analysis shown, if neither partner is a carrier then it is considered 
that the chance of having a child with cystic fibrosis is low.   Explain why the 
probability of having a child with cystic fibrosis is low and not zero.
(2)
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
 
(d) In the risk analysis shown, if one of the partners is found to be a carrier then 
screening for cystic fibrosis may be offered to other family members.  Explain why 
this screening is offered to other family members.
(2)
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
PMT


--- Page Break ---

20
*N35899A02024*
 
(e) Using your knowledge of monohybrid crosses, calculate the probability of having 
a child with cystic fibrosis if both partners are found to be carriers.  Draw a genetic 
diagram to explain how you calculated this probability.
(5)
                                                                                                                          Answer  ..................................................................
(Total for Question 7 = 13 marks)
PMT


--- Page Break ---

21
*N35899A02124*
Turn over  
8 Obesity is a significant problem in western countries and an increasing problem in 
other parts of the world.  An obese person has a greater risk of developing heart 
disease.  
 
Body Mass Index (BMI) is one measure used to help decide if a person’s weight is 
reasonable for their height.  The BMI can be calculated by dividing mass in kilograms 
by height in metres squared.  A table is then used to judge if the BMI is reasonable or 
not.  A copy of this table is shown below.
BMI range
Less than 18.5
18.5 to 24.9
25.0 to 29.9
30.0 to 39.9
40.0 or above
Description
Underweight
Healthy 
weight
Overweight
Obese
Morbidly 
obese
 
(a) A man was concerned that he was overweight and could be at risk from coronary 
heart disease.  He was 1.8 m tall and had a mass of 83.0 kg.
 
 
(i) 
Calculate this man’s body mass index (BMI) using the formula below.
mass in kilogrammes
(height in metres)2
BMI =
(2)
                                                                                                                          Answer  ..................................................................
 
 
(ii) Using the information in the table, interpret this man’s BMI.
(2)
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
PMT


--- Page Break ---

22
*N35899A02224*
 
(b) The graph below shows one analysis of relative mortality compared with BMI, for 
men and women.
 
 
Compare the effect of BMI on relative mortality for men and women.
(3)
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
Relative mortality
2.5
2.0
1.5
1.0
0.5
Men
Women
0
20
BMI
25
30
35
40
45
0
PMT


--- Page Break ---

23
*N35899A02324*
 
(c) (i) 
A relative mortality of 1.2 or less indicates a low risk of dying.  Using the 
information given, discuss whether or not a woman with a BMI of 32.5 should 
be concerned about her risk of dying.
(2)
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
 
 
*(ii) Cardiovascular disease (CVD) is responsible for many deaths.
 
 
 
Describe two changes that this woman may be able to make to her lifestyle, 
to reduce her risk of dying from CVD.  Explain how each change would reduce 
the risk.
(4)
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
(Total for Question 8 = 13 marks)
 TOTAL FOR PAPER = 80 MARKS
PMT


--- Page Break ---

24
*N35899A02424*
BLANK PAGE
PMT
